
Bestselling author Colleen Hoover is sharing a health update with her many readers and fans.
The "It Ends with Us" author revealed she was diagnosed with cancer and underwent treatment in an Instagram story photo post Monday, writing, "Second to last day of radiation! I wish I could blame my hair and facial expressions on @texas.oncology but they've been great. Hope you never need them, but highly recommend them."
In an earlier Facebook post on Friday, Hoover wrote that she had received test results back from a geneticist that explained her cancer did not stem from "family genes" and was not tied to HPV or hormonal factors.
More people are living 5 years after cancer diagnosis, new data shows
She added that she was "happy and grateful to be alive."
Hoover has not revealed the type of cancer with which she was diagnosed.
The author was noticeably absent from the October 2025 premiere for the movie "Regretting You," which was adapted from her 2019 book of the same name.
"I'm super bummed, but am having an unavoidable surgery and can't travel for a while," Hoover wrote in an Instagram post at the time.
Hoover's latest book, "Woman Down," is out Jan. 13.
LATEST POSTS
- 1
A Past filled with Old Civilizations: The World's Most established Societies - 2
New method spots signs of Earth's primordial life in ancient rocks - 3
Chicago reports first rabies-positive dog in 61 years. What we know. - 4
Illustrations Gained from a Crosscountry Excursion - 5
Instructions to Pick the Right Gold Speculation Procedure: Exploring the Market
Shas threatens to oppose 2026 state budget over haredi food-voucher exclusion
Iran denies launching ballistic missiles towards Kurdistan region of Iraq
Emergency services search for five people last seen in missing Jeep
US EPA will reassess safety of herbicide paraquat, says its chief
Misjudged Objections For Solo Voyagers
The Manual for Decent European Urban communities in 2024
6 Exercises to Anticipate in 2024
4 Creative Savvy Home Gadgets of 2024: Reforming Home Robotization and Security
MacArthur Foundation awards $100M to outbreak surveillance network, a boost amid global health cuts













